Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Feb 19:9:104.
doi: 10.1186/1471-2105-9-104.

PDTD: a web-accessible protein database for drug target identification

Affiliations

PDTD: a web-accessible protein database for drug target identification

Zhenting Gao et al. BMC Bioinformatics. .

Abstract

Background: Target identification is important for modern drug discovery. With the advances in the development of molecular docking, potential binding proteins may be discovered by docking a small molecule to a repository of proteins with three-dimensional (3D) structures. To complete this task, a reverse docking program and a drug target database with 3D structures are necessary. To this end, we have developed a web server tool, TarFisDock (Target Fishing Docking) http://www.dddc.ac.cn/tarfisdock, which has been used widely by others. Recently, we have constructed a protein target database, Potential Drug Target Database (PDTD), and have integrated PDTD with TarFisDock. This combination aims to assist target identification and validation.

Description: PDTD is a web-accessible protein database for in silico target identification. It currently contains >1100 protein entries with 3D structures presented in the Protein Data Bank. The data are extracted from the literatures and several online databases such as TTD, DrugBank and Thomson Pharma. The database covers diverse information of >830 known or potential drug targets, including protein and active sites structures in both PDB and mol2 formats, related diseases, biological functions as well as associated regulating (signaling) pathways. Each target is categorized by both nosology and biochemical function. PDTD supports keyword search function, such as PDB ID, target name, and disease name. Data set generated by PDTD can be viewed with the plug-in of molecular visualization tools and also can be downloaded freely. Remarkably, PDTD is specially designed for target identification. In conjunction with TarFisDock, PDTD can be used to identify binding proteins for small molecules. The results can be downloaded in the form of mol2 file with the binding pose of the probe compound and a list of potential binding targets according to their ranking scores.

Conclusion: PDTD serves as a comprehensive and unique repository of drug targets. Integrated with TarFisDock, PDTD is a useful resource to identify binding proteins for active compounds or existing drugs. Its potential applications include in silico drug target identification, virtual screening, and the discovery of the secondary effects of an old drug (i.e. new pharmacological usage) or an existing target (i.e. new pharmacological or toxic relevance), thus it may be a valuable platform for the pharmaceutical researchers. PDTD is available online at http://www.dddc.ac.cn/pdtd/.

PubMed Disclaimer

Figures

Figure 1
Figure 1
PDTD system architecture. The system is implemented in MySQL and PHP script, user can freely access the database at .
Figure 2
Figure 2
Functional and biochemical classifications of PDTD protein entries. (A) Database redundancy. Each bar represents the number of targets that have the same amounts of copies in the PDTD. Break is applied to the y axes. (B) Distribution of drug targets according to their therapeutic areas. (C) Distribution of drug targets according to their biochemical criteria, which include enzymes, receptors, ion channels, transporters, nuclear receptors, binding protein, structural proteins, signaling protein, and factors, regulators and hormones.
Figure 3
Figure 3
Screen shots of the PDTD. A screen shot of the PDTD showing several possible view of information describing the drug target. Not all fields are shown.

References

    1. Drews J. Drug discovery: a historical perspective. Science. 2000;287:1960–1964. doi: 10.1126/science.287.5460.1960. - DOI - PubMed
    1. Hopkins AL, Groom CR. The druggable genome. Nat Rev Drug Discov. 2002;1:727–730. doi: 10.1038/nrd892. - DOI - PubMed
    1. Russ AP, Lampel S. The druggable genome: an update. Drug Discov Today. 2005;10:1607–1610. doi: 10.1016/S1359-6446(05)03666-4. - DOI - PubMed
    1. Kitchen DB, Decornez H, Furr JR, Bajorath J. Docking and scoring in virtual screening for drug discovery: methods and applications. Nat Rev Drug Discov. 2004;3:935–949. doi: 10.1038/nrd1549. - DOI - PubMed
    1. Sperandio O, Miteva MA, Delfaud F, Villoutreix BO. Receptor-based computational screening of compound databases: the main docking-scoring engines. Curr Protein Pept Sci. 2006;7:369–393. doi: 10.2174/138920306778559377. - DOI - PubMed

Publication types